At Delta Life Science, we are at the forefront of label-free biosensing innovation. Since our spin-off from TNO in 2018, we have been revolutionising biomolecular analysis with the inQuiQ®, a cutting-edge biosensing instrument powered by Nanophotonic Evanescent field Sensing (NES) technology.

This advanced technology integrates up to 16 sensors on a single chip, enabling high-throughput measurement of biomolecular interactions from minimal sample volumes. For quantification or measuring kinetics of proteins, antibodies, DNA, peptides, or small molecules, inQuiQ® delivers precise results.

Our regenerable sensors allow for repeated use, maximising efficiency and reducing costs. With the inQuiQ®, we're empowering researchers and scientists to accelerate discoveries in life sciences.